IV iron dextran is most cost-effective, yielding 19.26 QALYs compared with 19.10 QALYs for oral ferrous sulfate.

Intravenous (IV) iron therapy is more effective than oral drugs for women with anemia and heavy periods, providing better ...

A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and ...

Intravenous (IV) iron use overall is associated with a “very low” risk for anaphylaxis, but iron dextran and ferumoxytol carry an increased risk relative to iron sucrose, according to new research.

A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia ...

The chances of a severe allergic reaction being triggered by intravenous (IV) iron formulations for anemia are higher with some than others, but all pose a low risk, a new study says. Researchers ...

IntravenoIron Drugs Market, By Product (Iron Dextran, Iron Sucrose, Ferric Carboxymaltose, and Others), By Application (Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer, and Others), and By ...